These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32210637)

  • 1. Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review.
    Yang Y; Boucoiran I; Tulloch KJ; Poliquin V
    Int J Womens Health; 2020; 12():159-170. PubMed ID: 32210637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.
    Tulloch KJ; Dodin P; Tremblay-Racine F; Elwood C; Money D; Boucoiran I
    J Int AIDS Soc; 2019 Jun; 22(6):e25322. PubMed ID: 31183987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review.
    Harris K; Murphy KE; Horn D; MacGilivray J; Yudin MH
    J Obstet Gynaecol Can; 2020 Mar; 42(3):308-315.e20. PubMed ID: 31285168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of cabergoline vs pyridoxine for lactation inhibition-a randomized controlled trial.
    Dayan-Schwartz A; Yefet E; Massalha M; Hosari-Mhameed S; Remer-Gross C; Pasand E; Nachum Z
    Am J Obstet Gynecol; 2024 May; 230(5):561.e1-561.e8. PubMed ID: 37827268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials.
    Shrateh ON; Kumar KA; Jawed A; Shuja MH; Shamsi HUR; Naasan M
    J Gynecol Obstet Hum Reprod; 2024 Jun; 53(6):102783. PubMed ID: 38554942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cabergoline for lactation inhibition in women living with HIV.
    Boucoiran I; Roy M; Poliquin V; Elwood C; Sheehan NL; Thibaudeau R; Ferreira E; Autmizguine J; Kakkar F; Boucher M; Money D; Tulloch K
    Int J STD AIDS; 2021 Jun; 32(7):654-661. PubMed ID: 33612017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabergoline for postpartum lactation suppression: Effect on blood pressure and pulse.
    Humphrey S; Baechler M; Schiff M; Hitti J
    Int J Gynaecol Obstet; 2022 Dec; 159(3):776-782. PubMed ID: 35304744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for suppression of lactation.
    Oladapo OT; Fawole B
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD005937. PubMed ID: 22972088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Study of Early Postpartum Excessive Breast Engorgement: Is it Related to Feedback Inhibition of Lactation?
    Coban A; Bayraktar S; Yıldız N; Tunçel D; Gökçay G; Ince Z
    J Hum Lact; 2021 May; 37(2):414-418. PubMed ID: 33030995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for suppression of lactation.
    Oladapo OT; Fawole B
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005937. PubMed ID: 19160258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline: a new drug for the treatment of hyperprolactinaemia.
    Ferrari C; Piscitelli G; Crosignani PG
    Hum Reprod; 1995 Jul; 10(7):1647-52. PubMed ID: 8582955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad S; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review.
    Snellen M; Power J; Blankley G; Galbally M
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):336-40. PubMed ID: 27297803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.